OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease
Nasimudeen R. Jabir, Shazi Shakil, Shams Tabrez, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 14, pp. 5083-5092
Open Access | Times Cited: 41
Nasimudeen R. Jabir, Shazi Shakil, Shams Tabrez, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 14, pp. 5083-5092
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review
Victor T. Sabe, Thandokuhle Ntombela, Lindiwe A. Jhamba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113705-113705
Closed Access | Times Cited: 436
Victor T. Sabe, Thandokuhle Ntombela, Lindiwe A. Jhamba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113705-113705
Closed Access | Times Cited: 436
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats
Shanji Nan, Peng Wang, Yizhi Zhang, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2013-2024
Open Access | Times Cited: 58
Shanji Nan, Peng Wang, Yizhi Zhang, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2013-2024
Open Access | Times Cited: 58
High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer’s Disease through Multitarget Approach
Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 937-937
Open Access | Times Cited: 45
Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 937-937
Open Access | Times Cited: 45
Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment
Nasimudeen R. Jabir, Md Tabish Rehman, Khadeejah Alsolami, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 2332-2344
Open Access | Times Cited: 42
Nasimudeen R. Jabir, Md Tabish Rehman, Khadeejah Alsolami, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 2332-2344
Open Access | Times Cited: 42
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
Najmeh Oliyaei, Marzieh Moosavi‐Nasab, Nader Tanideh, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 11-21
Open Access | Times Cited: 35
Najmeh Oliyaei, Marzieh Moosavi‐Nasab, Nader Tanideh, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 11-21
Open Access | Times Cited: 35
Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation
Anuraj Nayarisseri, Ravina Khandelwal, Maddala Madhavi, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 24, pp. 2146-2167
Closed Access | Times Cited: 42
Anuraj Nayarisseri, Ravina Khandelwal, Maddala Madhavi, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 24, pp. 2146-2167
Closed Access | Times Cited: 42
Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study
Adel Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 23
Adel Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 23
Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 5
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 5
Synthesis of novel sulphonamide derivatives from tunable quinolines with computational studies
Nagesh Dhanaji Chavan, S. Sarveswari, V. Vijayakumar
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nagesh Dhanaji Chavan, S. Sarveswari, V. Vijayakumar
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic
Ghazala Muteeb, Adil Alshoaibi, Mohammad Aatif, et al.
Applied Biological Chemistry (2020) Vol. 63, Iss. 1
Open Access | Times Cited: 33
Ghazala Muteeb, Adil Alshoaibi, Mohammad Aatif, et al.
Applied Biological Chemistry (2020) Vol. 63, Iss. 1
Open Access | Times Cited: 33
Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study
Mohammad Aatif, Ghazala Muteeb, Abdulrahman Alsultan, et al.
Marine Drugs (2021) Vol. 19, Iss. 5, pp. 242-242
Open Access | Times Cited: 29
Mohammad Aatif, Ghazala Muteeb, Abdulrahman Alsultan, et al.
Marine Drugs (2021) Vol. 19, Iss. 5, pp. 242-242
Open Access | Times Cited: 29
Nanomedicine-based immunotherapy for Alzheimer's disease
Mehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104973-104973
Closed Access | Times Cited: 20
Mehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104973-104973
Closed Access | Times Cited: 20
Discovery of Potent Parthenolide Derivatives Against Triple‐Negative Breast Cancer Using 3D‐QSAR, Virtual Screening, and Molecular Dynamics
Faiza Asli, Saida Khamoulı, Md Tabish Rehman, et al.
ChemistrySelect (2025) Vol. 10, Iss. 9
Closed Access
Faiza Asli, Saida Khamoulı, Md Tabish Rehman, et al.
ChemistrySelect (2025) Vol. 10, Iss. 9
Closed Access
Virtual screening and molecular dynamics of anti-Alzheimer compounds from Cardiospermum halicacabum via GC-MS
Selvan Kaviyarasu, Nallamuthu Padmanaban, Sulekha Khute, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Selvan Kaviyarasu, Nallamuthu Padmanaban, Sulekha Khute, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Exploring the Binding Pattern of Geraniol with Acetylcholinesterase through In Silico Docking, Molecular Dynamics Simulation, and In Vitro Enzyme Inhibition Kinetics Studies
Danish Iqbal, M. Salman Khan, Mohd Waiz, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3533-3533
Open Access | Times Cited: 24
Danish Iqbal, M. Salman Khan, Mohd Waiz, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3533-3533
Open Access | Times Cited: 24
Identification of anticancer bioactive compounds derived from Ficus sp. by targeting Poly[ADP-ribose]polymerase 1 (PARP-1)
Shams Tabrez, Mehboob Hoque, Mohd Suhail, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 5, pp. 102079-102079
Open Access | Times Cited: 17
Shams Tabrez, Mehboob Hoque, Mohd Suhail, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 5, pp. 102079-102079
Open Access | Times Cited: 17
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
Kamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Kamila Czarnecka, Małgorzata Girek, Paweł Kręcisz, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina: Possible Implication in Cancer Therapy
Adel Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 15
Adel Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 15
Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer’s Disease
Danish Iqbal, Md Tabish Rehman, Mohamed F. Alajmi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 622-622
Open Access | Times Cited: 8
Danish Iqbal, Md Tabish Rehman, Mohamed F. Alajmi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 622-622
Open Access | Times Cited: 8
Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer’s Treatment: A Computational Strategy
Nasimudeen R. Jabir, Md Tabish Rehman, Shams Tabrez, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 20, pp. 2425-2434
Closed Access | Times Cited: 19
Nasimudeen R. Jabir, Md Tabish Rehman, Shams Tabrez, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 20, pp. 2425-2434
Closed Access | Times Cited: 19
Novel Benzimidazol‐2‐Thione Derivatives: Synthesis, In Vitro Anticancer, Antimicrobial Activities, And In Silico Molecular Docking Study
Ngo Duy Tuy Ha, Trương Thị Bích Phượng, Nguyen Van Cuong, et al.
ChemistrySelect (2023) Vol. 8, Iss. 17
Closed Access | Times Cited: 7
Ngo Duy Tuy Ha, Trương Thị Bích Phượng, Nguyen Van Cuong, et al.
ChemistrySelect (2023) Vol. 8, Iss. 17
Closed Access | Times Cited: 7
New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease
Iohanan Daniel García Marín, Raúl Horacio Camarillo-López, Oscar Aurelio Martínez, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269129-e0269129
Open Access | Times Cited: 12
Iohanan Daniel García Marín, Raúl Horacio Camarillo-López, Oscar Aurelio Martínez, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269129-e0269129
Open Access | Times Cited: 12
Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders
Danish Iqbal, Mohammed Alsaweed, Qazi Mohammad Sajid Jamal, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1613-1613
Open Access | Times Cited: 6
Danish Iqbal, Mohammed Alsaweed, Qazi Mohammad Sajid Jamal, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1613-1613
Open Access | Times Cited: 6
Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches
Ghazala Muteeb, Md Tabish Rehman, Mohamed F. Alajmi, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5930-5930
Open Access | Times Cited: 10
Ghazala Muteeb, Md Tabish Rehman, Mohamed F. Alajmi, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5930-5930
Open Access | Times Cited: 10
Fluorenone–thiazolidine-4-one scaffolds as antidiabetic and antioxidant agents: design, synthesis, X-ray crystal structures, and binding and computational studies
Manasa A. Doddagaddavalli, Veerendra Kumar A. Kalalbandi, Tejas R. Naik, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 28, pp. 13581-13599
Closed Access | Times Cited: 5
Manasa A. Doddagaddavalli, Veerendra Kumar A. Kalalbandi, Tejas R. Naik, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 28, pp. 13581-13599
Closed Access | Times Cited: 5
